PAHC

$0.00

(

+0.00%

)
Quote details

stock

Phibro Animal Health Corporation

NASDAQ | PAHC

30.96

USD

+0.00

(

+0.00%

)

AT CLOSE (AS OF Aug 13, 2025)

$1.2B

MARKET CAP

38.05

P/E Ratio

0.78

EPS

$32

52 Week High

$16

52 Week Low

LIFE SCIENCES

Sector

PAHC Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback's Trading Journal

PAHC Technicals

Tags:

PAHC Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field Value (USD)
Gross Profit $313M
Total Revenue $1B
Cost Of Revenue $705M
Costof Goods And Services Sold $705M
Operating Income $53M
Selling General And Administrative $260M
Research And Development $29M
Operating Expenses $260M
Investment Income Net -
Net Interest Income -$19M
Interest Income $4.5M
Interest Expense $38M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $36M
Income Before Tax $11M
Income Tax Expense $8.5M
Interest And Debt Expense -
Net Income From Continuing Operations $2.4M
Comprehensive Income Net Of Tax -
Ebit $48M
Ebitda $85M
Net Income $2.4M

Revenue & Profitability

Earnings Performance

PAHC Financials

yearly Balance Sheet (As of Jun 30, 2024)

Field Value (USD)
Total Assets $982M
Total Current Assets $601M
Cash And Cash Equivalents At Carrying Value $71M
Cash And Short Term Investments $71M
Inventory $266M
Current Net Receivables $169M
Total Non Current Assets $381M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $45M
Intangible Assets Excluding Goodwill $45M
Goodwill $55M
Investments -
Long Term Investments $11M
Short Term Investments $44M
Other Current Assets $51M
Other Non Current Assets -
Total Liabilities $726M
Total Current Liabilities $204M
Current Accounts Payable $86M
Deferred Revenue -
Current Debt -
Short Term Debt $37M
Total Non Current Liabilities $521M
Capital Lease Obligations $37M
Long Term Debt $458M
Current Long Term Debt $30M
Long Term Debt Noncurrent -
Short Long Term Debt Total $525M
Other Current Liabilities $78M
Other Non Current Liabilities $6.8M
Total Shareholder Equity $257M
Treasury Stock -
Retained Earnings $244M
Common Stock $4K
Common Stock Shares Outstanding $41M

yearly Cash Flow (As of Jun 30, 2024)

Field Value (USD)
Operating Cashflow $88M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $36M
Capital Expenditures $41M
Change In Receivables -
Change In Inventory $2.6M
Profit Loss -
Cashflow From Investment -$48M
Cashflow From Financing -$6.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $19M
Dividend Payout Common Stock $19M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $2.4M

yearly Income Statement (As of Jun 30, 2024)

Field Value (USD)
Gross Profit $313M
Total Revenue $1B
Cost Of Revenue $705M
Costof Goods And Services Sold $705M
Operating Income $53M
Selling General And Administrative $260M
Research And Development $29M
Operating Expenses $260M
Investment Income Net -
Net Interest Income -$19M
Interest Income $4.5M
Interest Expense $38M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $36M
Income Before Tax $11M
Income Tax Expense $8.5M
Interest And Debt Expense -
Net Income From Continuing Operations $2.4M
Comprehensive Income Net Of Tax -
Ebit $48M
Ebitda $85M
Net Income $2.4M

Dividends

Field Value
Ex Dividend Date 2025-06-04
Declaration Date 2025-05-06
Record Date 2025-06-04
Payment Date 2025-06-25
Amount 0.12

PAHC News

PAHC Profile

Phibro Animal Health Corporation Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.

Discover more tools and features to empower your trading
Explore Features

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.